Nature Vet Ceva
Nature Vet has its origins in a successful equine veterinary practice which operated in Australia during the 1970s. In order to provide high quality, specialised veterinary products for their equine patients, two of the vets (Dr. G. A. Rose and Dr. L. Whatmore) enlisted the aid of an innovative chemist to form a manufacturing company called RWR.
In 1983, Drs. Rose and Whatmore formed a separate company, Nature Vet Pty. Ltd., to develop new, natural products. In 1986, RWR was separated from the veterinary practice, and in 1988 this company was amalgamated with Nature Vet. Dr. Gerry Rose and his wife, Helen, assumed full control of Nature Vet in 1995.
During 1999, Nature Vet acquired Biochemical Veterinary Research Pty. Ltd., which expanded the product range and key academic research and development relationships.
The Company continued its expansion, and in 2002 consolidated its activities in a new facility at Glenorie, a north‐west suburb of Sydney, Australia. This site is a GMP accredited facility with sufficient potential to continue the Company's planned expansion.
The origins of Nature Vet in an equine veterinary practice reflected a close relationship between the Company, the veterinarian and the equine patient.
CEVA ANIMAL HEALTH
In July 2010, the Ceva Santé Animale group finalized the acquisition of Nature Vet.
Ceva had already established its presence in Australia in 2007 with the acquisition of the company Delvet. With the acquisition of Nature Vet, the Ceva pharmaceutical company, amongst the top ten ranking worldwide, strengthed its position and became a major actor on a rapidly growing market which, just like its economy, escaped the crisis.
Ceva had already targeted the companion animal sector as one of its main strategic axes of development. With the acquisition of Nature Vet, the company will further strengthen its product portfolios mainly in the equine range.
The Australian laboratory (Nature Vet), a family company established in 1983, will benefit from the worldwide presence of Ceva in 45 other countries to considerably widen its market.